Navigation Links
Biotech executive books a career flight that's closer to home

Madison, Wis. - Gregg Fergus can tell his fellow travelers a thing or two about commuting.

The Madison native has joined Baird Venture Partners as an executive-in-residence and one of its portfolio companies, Caden Biosciences, as senior vice president of corporate development.

......

Full article >>> Equity, said Fergus would reinforce Baird's focus on the life-science tools market. He expects Fergus to help Baird's healthcare and life science teams evaluate new investment opportunities, and manage its current portfolio of companies. Baird Private Equity has raised and managed $1.8 billion in capital.

Gregg brings operational experience and perspective that will help us in a number o......

Full article >>> re from 800 to 1,000 GPCRs on the human genome. Of those, roughly 400 are thought to be pharmaceutically relevant, but only 40 have been successfully targeted by commercial drugs - representing $50 billion in annual sales - and many of those drugs have side effects.

Caden Biosciences might be able to partner with a big pharma company to pinpoint the remaining intractable targets, and addr......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/19/07


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Gala Biotech among companies sold for $3.3 billion
3. Biotech with Madison ties raises $21M in capital
4. Biotech firm uses live heart tissue in drug screens
5. Biotech talent drew venture-funded firm to Madison
6. Biotech firm has strokes, Alzheimers in its sights
7. 42 days until the 2006 Olympics of Biotechnology in Chicago
8. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
9. Biotech leads list of top U.S. companies to work for
10. Biotech flourishes in 2005 while Big Pharma is on the decline
11. Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... 28, 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: ... compelling safety and clinical data from its phase 1/2 tendon ... hair follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... ... safety profile at 6 months and showed no serious adverse ...
(Date:3/27/2017)... N.J. , March 27, 2017 Roka Bioscience, ... advanced testing solutions for the detection of foodborne pathogens,  today ... the Sidoti & Company Spring 2017 Convention on March 29 ... New York Marriott Marquis. About Roka Bioscience ... ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biopsies from non-small cell lung ... limited tumor content in a large background of normal or wild type cells. ... for reliable detection of low abundance somatic mutations, particularly in small specimens with ...
(Date:3/27/2017)... 2017  Perthera,s Chief Bioinformatics Officer and research faculty ... , Ph.D., will be speaking at the American Medical ... March 27, 2017, she will be speaking on the ... Research and Care" (from 10:30 a.m. – 12:00 p.m. ... be a participant in the "Making Precision Oncology Data ...
Breaking Biology Technology:
(Date:2/28/2017)... February 28, 2017 News solutions for biometrics, ... ... from 14 to 16 March, Materna will present its ... how seamless travel is a real benefit for passengers. To ... to their passenger touch point solutions to take passengers through the ...
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader of ... elite iris biometric solution on the latest Qualcomm® ... at Mobile World Congress 2017 (February 27 ... in Hall 3, Stand 3E10. ... Haven™ security platform—a combination of hardware, software ...
Breaking Biology News(10 mins):